Preclinical studies sometimes use supraphysiological concentrations of compounds. Could supraphysiologic doses of CBD, for example, impact study results?
Yes. The observed effects of supraphysiologic doses of CBD may not be caused by a specific binding of CBD to one of its receptors, but instead may be due to unspecific binding. This unspecific binding can inactivate the receptor or transporter.